Brian Schwartz Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

Brian Schwartz is Interim Chief Medical Officer of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 15,205 shares of CYCC, which is worth approximately $4,865. The most recent transaction as insider was on Jan 29, 2024, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.2K
0% 3M change
62.55% 12M change
Total Value Held $4,865

BRIAN SCHWARTZ Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 29 2024
BUY
Grant, award, or other acquisition
-
12,500 Added 45.12%
15,205 Common Stock
Jun 30 2023
BUY
Grant, award, or other acquisition
-
21,219 Added 34.32%
40,602 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
15,822 Added 44.94%
19,383 Common Stock
Jun 15 2021
BUY
Grant, award, or other acquisition
-
3,561 Added 50.0%
3,561 Common Stock

Also insider at

INFI
INFINITY PHARMACEUTICALS, INC. Healthcare
BS

Brian Schwartz

Interim Chief Medical Officer
Berkeley Heights, NJ

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC